Vermilion Energy Inc. T.VET

Alternate Symbol(s): VET

Energy Oil & Gas E&P

Vermilion Energy Inc. is a Canada-based international energy producer. The Company seeks to create value through the acquisition, exploration, development, and optimization of producing assets in North America, Europe, and Australia. Its business model emphasizes free cash flow generation and returning capital to investors when economically warranted, augmented by value-adding acquisitions. The Company’s operations are focused on the exploitation of light oil and liquids-rich natural gas conventional and unconventional resource plays in North America and the exploration and development of conventional natural gas and oil opportunities in Europe and Australia. The Company operates through seven geographical segments: Canada, the United States, France, Netherlands, Germany, Ireland, and Australia. In Canada, the Company is a key player in the highly productive Mannville condensate-rich gas play. It holds a 100% working interest in the Wandoo field, offshore Australia.

TSX:VET - Post by User

Vermilion Energy Inc.

Bullboard Posts

Comment by Sadie222on Feb 25, 2020 3:38am

70 Views

Post# 30729117

RE:40-60% will be infected by coronavirus globally

Considering how many people we have travelling to and from countries with the virus (especially Asian) and how low our infection count still is, I sleep very well at night. Your 40% number is nonsense.

WheresMeGold wrote: There are some estimating that 40-60% of all people globally will be infected over the next year. 40% of the 7.7 billion people on Earth with a 1% mortality rate is 30.8 million deaths. Current mortality rates for coronavirus is estimated higher at 2-5%, which equates to 61.6 million to 154 million deaths.

Hopefully these estimates are at least a few orders of magnitudes too high. However, it demonstrates that the coronavirus will have a huge impact on a human level and an economic level. Markets have not come to terms with this fully. Energy companies are particularly vulnerable.

https://www.theatlantic.com/health/archive/2020/02/covid-vaccine/607000/